Soleno Therapeutics (SLNO) Interest Coverage Ratio (2013 - 2026)
Soleno Therapeutics' (SLNO) quarterly Interest Coverage Ratio came in at 1.15 in Q1 2026, up 103.42% year-on-year from 0.56 in Q1 2025, and down 96.47% on a QoQ basis from 32.49 in Q4 2025.
Soleno Therapeutics (SLNO) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of Interest Coverage Ratio data on file, last reported at 1.15 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 103.42% year-over-year to 1.15 in Q1 2026; TTM through Mar 2026 was 3.17, a 101.81% increase from a year earlier, with the FY2025 full-year figure at 0.12, up 105.24% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1.15, down from 32.49 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for SLNO reached as high as 3477.41 in Q4 2024 and fell as low as 16208.65 in Q2 2023.
- Historically, Interest Coverage Ratio has averaged 753.43 across 5 years, with a median of 0.3 in 2024.
- On a YoY basis, Interest Coverage Ratio climbed as much as 53650.64% in 2023 and fell as far as 84541.7% in 2023.
- Year by year, Interest Coverage Ratio stood at 0.1 in 2022, then surged by 53650.64% to 52.69 in 2023, then soared by 6499.83% to 3477.41 in 2024, then sank by 99.07% to 32.49 in 2025, then sank by 96.47% to 1.15 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 1.15 in Q1 2026, 32.49 in Q4 2025, and 0.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 1.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 |
| Dec 31, 2025 | 32.49 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | -0.04 |
| Mar 31, 2025 | -33.61 |
| Dec 31, 2024 | 3,477.41 |
| Sep 30, 2024 | -0.83 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | 52.69 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -16,208.65 |
| Mar 31, 2023 | -71.17 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -25.04 |
| Jun 30, 2022 | -19.15 |
| Mar 31, 2022 | -12.83 |
| Dec 31, 2021 | -0.06 |
| Sep 30, 2021 | -167.08 |
| Jun 30, 2021 | -18.06 |